SGLT2-话题@MedSci

#SGLT2#

82篇内容 | 3039人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1503779, encodeId=d28d1503e7941, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=JCEM：SGLT2抑制剂增加了糖尿病酮症酸中毒的风险, objectType=article, longId=161782, objectId=aad0161e82c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aad0161e82c0, replyNumber=0, likeNumber=50, createdTime=2019-03-08, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aad0161e82c0, moduleTitle=JCEM：SGLT2抑制剂增加了糖尿病酮症酸中毒的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aad0161e82c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503778, encodeId=3fb01503e78e8, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Diabetes Obes Metab：SGLT2抑制剂对2型糖尿病和慢性肾病患者的心血管、肾脏和安全性结局的影响, objectType=article, longId=159506, objectId=5b8515950618, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b8515950618, replyNumber=0, likeNumber=33, createdTime=2019-02-06, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b8515950618, moduleTitle=Diabetes Obes Metab：SGLT2抑制剂对2型糖尿病和慢性肾病患者的心血管、肾脏和安全性结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b8515950618)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503777, encodeId=532b1503e77d2, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=观察性研究中使用SGLT2抑制剂死亡风险较低：真实还是偏倚？, objectType=article, longId=159182, objectId=207b1591827c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=207b1591827c, replyNumber=0, likeNumber=80, createdTime=2019-01-31, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=207b1591827c, moduleTitle=观察性研究中使用SGLT2抑制剂死亡风险较低：真实还是偏倚？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=207b1591827c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503776, encodeId=b9411503e7686, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Sci Transl Me：穿越！降糖靶点SGLT2竟然可以辅助肺腺癌早检，获批降糖药有望用于治疗, objectType=article, longId=153661, objectId=4d1e15366120, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d1e15366120, replyNumber=0, likeNumber=67, createdTime=2018-11-17, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d1e15366120, moduleTitle=Sci Transl Me：穿越！降糖靶点SGLT2竟然可以辅助肺腺癌早检，获批降糖药有望用于治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d1e15366120)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503775, encodeId=171a1503e758d, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Lancet：SGLT2抑制剂对II型糖尿病患者心血管及肾功能的影响研究, objectType=article, longId=153311, objectId=986d15331165, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=986d15331165, replyNumber=0, likeNumber=58, createdTime=2018-11-14, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=986d15331165, moduleTitle=Lancet：SGLT2抑制剂对II型糖尿病患者心血管及肾功能的影响研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=986d15331165)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503774, encodeId=09ca1503e74f2, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Diabetes Obes Metab：与SGLT2抑制剂相关的生殖器感染风险分析, objectType=article, longId=148897, objectId=5a5a14889e0f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a5a14889e0f, replyNumber=0, likeNumber=43, createdTime=2018-09-17, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a5a14889e0f, moduleTitle=Diabetes Obes Metab：与SGLT2抑制剂相关的生殖器感染风险分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a5a14889e0f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503773, encodeId=23e51503e7304, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=FDA发出安全警告：2型糖尿病药物SGLT2抑制剂与严重的生殖器感染存在相关性, objectType=article, longId=147836, objectId=911e14e836f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=911e14e836f1, replyNumber=0, likeNumber=88, createdTime=2018-09-01, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=911e14e836f1, moduleTitle=FDA发出安全警告：2型糖尿病药物SGLT2抑制剂与严重的生殖器感染存在相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=911e14e836f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503772, encodeId=cd871503e7201, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Cardiovasc Diabetol：SGLT2抑制剂可否降低2型糖尿病患者的心衰风险？, objectType=article, longId=145809, objectId=5cde145809a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cde145809a9, replyNumber=0, likeNumber=86, createdTime=2018-08-05, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cde145809a9, moduleTitle=Cardiovasc Diabetol：SGLT2抑制剂可否降低2型糖尿病患者的心衰风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cde145809a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503771, encodeId=36d41503e71ff, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Sci rep：日本团队发现糖尿病治药 SGLT2 阻滞剂能延缓抑制非酒精脂肪肝炎及肝癌的发病及恶化, objectType=article, longId=141975, objectId=affd1419e50b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=affd1419e50b, replyNumber=0, likeNumber=73, createdTime=2018-07-01, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=affd1419e50b, moduleTitle=Sci rep：日本团队发现糖尿病治药 SGLT2 阻滞剂能延缓抑制非酒精脂肪肝炎及肝癌的发病及恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=affd1419e50b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503770, encodeId=a56d1503e70aa, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Lancet diabetes endo：度拉糖肽作为SGLT2抑制剂的补充治疗，用于血糖控制效果欠佳的2型糖尿病患者的效果和安全性, objectType=article, longId=130540, objectId=df9e130540b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df9e130540b9, replyNumber=0, likeNumber=46, createdTime=2018-02-26, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df9e130540b9, moduleTitle=Lancet diabetes endo：度拉糖肽作为SGLT2抑制剂的补充治疗，用于血糖控制效果欠佳的2型糖尿病患者的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df9e130540b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503769, encodeId=a3271503e6909, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=JAHA：2型糖尿病患者SGLT2抑制剂的心血管安全和长期非心血管疗效分析！, objectType=article, longId=127162, objectId=547a12e162f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=547a12e162f7, replyNumber=0, likeNumber=32, createdTime=2018-01-23, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=547a12e162f7, moduleTitle=JAHA：2型糖尿病患者SGLT2抑制剂的心血管安全和长期非心血管疗效分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=547a12e162f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503768, encodeId=5db01503e6810, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Circulation：SGLT2抑制剂能降低心衰患者的死亡率吗？, objectType=article, longId=124757, objectId=8268124e577a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8268124e577a, replyNumber=0, likeNumber=86, createdTime=2017-12-28, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8268124e577a, moduleTitle=Circulation：SGLT2抑制剂能降低心衰患者的死亡率吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8268124e577a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503767, encodeId=4d9f1503e6744, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Diabetes Care：SGLT2抑制剂增加2型糖尿病患者急性肾损伤风险吗？, objectType=article, longId=124719, objectId=55c6124e19ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55c6124e19ac, replyNumber=0, likeNumber=78, createdTime=2017-12-28, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55c6124e19ac, moduleTitle=Diabetes Care：SGLT2抑制剂增加2型糖尿病患者急性肾损伤风险吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55c6124e19ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503766, encodeId=96951503e6637, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Diabetologia：SGLT2抑制剂致2型糖尿病患癌症的风险, objectType=article, longId=117295, objectId=f03611e29509, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f03611e29509, replyNumber=0, likeNumber=60, createdTime=2017-10-25, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f03611e29509, moduleTitle=Diabetologia：SGLT2抑制剂致2型糖尿病患癌症的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f03611e29509)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503765, encodeId=fb991503e6548, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Lancet Diabetes Endo：2型糖尿病新用药者SGLT2抑制剂vs其他降糖药的心血管风险, objectType=article, longId=115490, objectId=c0a811549083, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0a811549083, replyNumber=0, likeNumber=59, createdTime=2017-10-11, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0a811549083, moduleTitle=Lancet Diabetes Endo：2型糖尿病新用药者SGLT2抑制剂vs其他降糖药的心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0a811549083)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503764, encodeId=d7d21503e64d4, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病：不同SGLT2抑制剂的肾脏风险几何？, objectType=article, longId=111943, objectId=f4a3111943f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4a3111943f6, replyNumber=0, likeNumber=76, createdTime=2017-09-06, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4a3111943f6, moduleTitle=Diabetes Obes Metab：2型糖尿病：不同SGLT2抑制剂的肾脏风险几何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4a3111943f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503763, encodeId=faf21503e63b1, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=Diabetes Care：SGLT2抑制剂服用者发生急性肾损伤的风险分析！, objectType=article, longId=110543, objectId=19a2110543e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19a2110543e3, replyNumber=0, likeNumber=33, createdTime=2017-08-24, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19a2110543e3, moduleTitle=Diabetes Care：SGLT2抑制剂服用者发生急性肾损伤的风险分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19a2110543e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503762, encodeId=a6691503e6291, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=J Am Heart Assoc：SGLT2抑制剂对24小时动态血压有何影响？, objectType=article, longId=104953, objectId=af4f10495358, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4f10495358, replyNumber=0, likeNumber=71, createdTime=2017-07-09, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4f10495358, moduleTitle=J Am Heart Assoc：SGLT2抑制剂对24小时动态血压有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af4f10495358)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503761, encodeId=bf031503e613c, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=JACC：在2型糖尿病老年患者中，钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂可降低心血管和心脏衰竭风险。, objectType=article, longId=102577, objectId=3a551025e7f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a551025e7f4, replyNumber=0, likeNumber=74, createdTime=2017-06-21, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a551025e7f4, moduleTitle=JACC：在2型糖尿病老年患者中，钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂可降低心血管和心脏衰竭风险。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a551025e7f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503760, encodeId=217d1503e601c, content=<a href='/topic/show?id=60b916226e1' target=_blank style='color:#2F92EE;'>#SGLT2#</a>, objectTitle=NEJM: SGLT2抑制剂可增加糖尿病酮酸症的患病风险, objectType=article, longId=101327, objectId=111310132efa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=111310132efa, replyNumber=0, likeNumber=56, createdTime=2017-06-11, rootId=0, userName=jiekemin, userId=3afa9693555, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=111310132efa, moduleTitle=NEJM: SGLT2抑制剂可增加糖尿病酮酸症的患病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=111310132efa)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SGLT2

2020-05-29

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

JCEM：SGLT2抑制剂增加了糖尿病酮症酸中毒的风险

2019-03-08

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

Diabetes Obes Metab：SGLT2抑制剂对2型糖尿病和慢性肾病患者的心血管、肾脏和安全性结局的影响

2019-02-06

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

观察性研究中使用SGLT2抑制剂死亡风险较低：真实还是偏倚？

2019-01-31

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

Sci Transl Me：穿越！降糖靶点SGLT2竟然可以辅助肺腺癌早检，获批降糖药有望用于治疗

2018-11-17

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

Lancet：SGLT2抑制剂对II型糖尿病患者心血管及肾功能的影响研究

2018-11-14

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

Diabetes Obes Metab：与SGLT2抑制剂相关的生殖器感染风险分析

2018-09-17

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

FDA发出安全警告：2型糖尿病药物SGLT2抑制剂与严重的生殖器感染存在相关性

2018-09-01

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

Cardiovasc Diabetol：SGLT2抑制剂可否降低2型糖尿病患者的心衰风险？

2018-08-05

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

Sci rep：日本团队发现糖尿病治药 SGLT2 阻滞剂能延缓抑制非酒精脂肪肝炎及肝癌的发病及恶化

2018-07-01

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

Lancet diabetes endo：度拉糖肽作为SGLT2抑制剂的补充治疗，用于血糖控制效果欠佳的2型糖尿病患者的效果和安全性

2018-02-26

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

JAHA：2型糖尿病患者SGLT2抑制剂的心血管安全和长期非心血管疗效分析！

2018-01-23

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

Circulation：SGLT2抑制剂能降低心衰患者的死亡率吗？

2017-12-28

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

Diabetes Care：SGLT2抑制剂增加2型糖尿病患者急性肾损伤风险吗？

2017-12-28

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

Diabetologia：SGLT2抑制剂致2型糖尿病患癌症的风险

2017-10-25

柳叶一刀 (审核中...)

前往app查看评论内容

#SGLT2#

Lancet Diabetes Endo：2型糖尿病新用药者SGLT2抑制剂vs其他降糖药的心血管风险

2017-10-11

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

Diabetes Obes Metab：2型糖尿病：不同SGLT2抑制剂的肾脏风险几何？

2017-09-06

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

Diabetes Care：SGLT2抑制剂服用者发生急性肾损伤的风险分析！

2017-08-24

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

J Am Heart Assoc：SGLT2抑制剂对24小时动态血压有何影响？

2017-07-09

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

JACC：在2型糖尿病老年患者中，钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂可降低心血管和心脏衰竭风险。

2017-06-21

jiekemin (审核中...)

前往app查看评论内容

#SGLT2#

NEJM: SGLT2抑制剂可增加糖尿病酮酸症的患病风险

2017-06-11

科室
- - 订阅+
  - 更多科室
工具
服务